Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Tam Makale Uluslararası 2020

Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

Bulent Degertekin, Mehmet Demir, ULUS SALİH AKARCA, HALUK TARIK KANİ, Enver Ucbilek, Emre Yildirim, Fatih Guzelbulut, Ayhan Balkan, Sezgin Vatansever, Nilay Danis, Melek Demircan, Aliye Soylu, Serkan Yaras, Aysun Kartal, Ayse Kefeli, Feyza Gunduz, Kendal Yalcin, Elife Erarslan, Murat Aladag, Murat Harputluoglu, Aysegul Ozakyol, Tuncer Temel, Mesut Akarsu, Hale Sumer, Mete Akin, Bülent Albayrak, Ilker Sen, Huseyin Alkim, Ahmet Uyanikoglu, Kader Irak, Sinem Oztaskin, Cagri Burak Ugurlu, Sevkican Gunes, Selim Gurel, Kenan Nuriyev, Ismail Inci, Sabite Kacar, Dinc Dincer, Levent Doganay, Huseyin Savas Gokturk, Ali Mert, Arif Mansur Cosar, Hakan Dursun, Roni Atalay, Sabiye Akbulut, Yasemin Balkan, Hayrettin Koklu, Halis Simsek, Osman Ozdogan, Mehmet Coban, Sule Poturoglu, Talat Ayyildiz, Suna Yapali, Fulya Gunsar, Meral Akdogan, Seren Ozenirler, Murat Akyildiz, Orhan Sezgin, Osman Ozdogan, Sabahattin Kaymakoglu, Fatih Besisik, Zeki Karasu, Ramazan Idilman

TURKISH JOURNAL OF GASTROENTEROLOGY Cilt 31 · Sayı 12 · ss. 883–893 · 01.12.2020
DOI ile aç

Özet

Background/Aims: This study aimed to evaluate the real-life efficacy and tolerability of direct-acting antiviral treatments for patients with chronic hepatitis C (CHC) with/without cirrhosis in the Turkish population.

Anahtar kelimeler

treatment INFECTION Turkey Hepatocellular carcinoma HCV ribavirin Cirrhosis direct-acting antiviral SUSTAINED VIROLOGICAL RESPONSE ACTING ANTIVIRAL THERAPY

Sürdürülebilir Kalkınma Amaçları

  • SKA 3: Sağlıklı Bireyler

Atıf için künye

Degertekin, B., Demir, M., AKARCA, U. S., KANİ, H. T., Ucbilek, E., Yildirim, E., Guzelbulut, F., Balkan, A., Vatansever, S., Danis, N., Demircan, M., Soylu, A., Yaras, S., Kartal, A., Kefeli, A., Gunduz, F., Yalcin, K., Erarslan, E., Aladag, M., … Idilman, R. (2020). Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. TURKISH JOURNAL OF GASTROENTEROLOGY, 31(12), 883–893. https://doi.org/10.5152/tjg.2020.20696

BibTeX
@article{degertekin2020-228243,
  author = {Degertekin, Bulent and Demir, Mehmet and AKARCA, ULUS SALİH and KANİ, HALUK TARIK and Ucbilek, Enver and Yildirim, Emre and Guzelbulut, Fatih and Balkan, Ayhan and Vatansever, Sezgin and Danis, Nilay and Demircan, Melek and Soylu, Aliye and Yaras, Serkan and Kartal, Aysun and Kefeli, Ayse and Gunduz, Feyza and Yalcin, Kendal and Erarslan, Elife and Aladag, Murat and Harputluoglu, Murat and Ozakyol, Aysegul and Temel, Tuncer and Akarsu, Mesut and Sumer, Hale and Akin, Mete and Albayrak, Bülent and Sen, Ilker and Alkim, Huseyin and Uyanikoglu, Ahmet and Irak, Kader and Oztaskin, Sinem and Ugurlu, Cagri Burak and Gunes, Sevkican and Gurel, Selim and Nuriyev, Kenan and Inci, Ismail and Kacar, Sabite and Dincer, Dinc and Doganay, Levent and Gokturk, Huseyin Savas and Mert, Ali and Cosar, Arif Mansur and Dursun, Hakan and Atalay, Roni and Akbulut, Sabiye and Balkan, Yasemin and Koklu, Hayrettin and Simsek, Halis and Ozdogan, Osman and Coban, Mehmet and Poturoglu, Sule and Ayyildiz, Talat and Yapali, Suna and Gunsar, Fulya and Akdogan, Meral and Ozenirler, Seren and Akyildiz, Murat and Sezgin, Orhan and Ozdogan, Osman and Kaymakoglu, Sabahattin and Besisik, Fatih and Karasu, Zeki and Idilman, Ramazan},
  title = {Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience},
  journal = {TURKISH JOURNAL OF GASTROENTEROLOGY},
  year = {2020},
  volume = {31},
  number = {12},
  pages = {883--893},
  issn = {1300-4948},
  doi = {10.5152/tjg.2020.20696},
  url = {https://akademik.atauni.edu.tr/yayinlar/228243-real-world-efficacy-and-safety-of-ledipasvir-plus-sofosbuvir-and}
}